
| Factor | Score | Distribution | Value | Avg | Rank |
|---|---|---|---|---|---|
Valuation | 26 | — | 17.3x | Bottom tier | |
Growth | 58 | — | 7.1% | Around median | |
Quality | 20 | -10.9% | 4.5% | Bottom tier | |
Safety | 53 | — | 2.6x | Around median | |
Capital Return | 15 | 0.00% | 0.06% | Bottom tier | |
Momentum | 3 | -77.7% | -1.6% | Bottom tier | |
Sentiment | 44 | 14 | 3 | Around median |
Oklo Inc., listed under the ticker OKLO on NYSE, is developing a nuclear platform that combines electricity and heat production, fuel supply, fabrication and recycling, and isotope production. The target Aurora model centers on developing, owning and operating power plants under long-term commercial arrangements, allowing the company to retain operating and fuel-service revenue throughout the asset's life cycle. Projects include Aurora INL, a planned 1.2 gigawatt complex in Ohio, and an application to supply Eielson Air Force Base with electricity and heat; however, not all activities within this platform have reached commercial operation.
Revenue for quarter 2 of fiscal year 2026, ended 2026-06-30, was approximately 1.2 million dollars, compared with negative net income of 48.5 million dollars and negative diluted earnings per share of 0.28 dollars. The operating margin was -6048.8%, reflecting the large gap between limited revenue and platform development costs. Operating cash flow was -47.6 million dollars in the same quarter, according to EL7 data. The company operates across energy, fuel and isotopes, but this quarter's results do not allow revenue to be attributed to each activity individually.
The Groves isotope reactor achieved its first sustained nuclear chain reaction by early August 2026, while management indicated on the 2026-08-07 call that the isotope business's first revenue would likely come from the Idaho laboratory before Groves. In quarter 2 of fiscal year 2026, ended 2026-06-30, cash and short-term investments totaled 1.6 billion dollars against total debt of 700000 dollars, according to EL7 data; the liquidity amount excludes long-term securities. Oklo therefore combines financial resources that support construction with an ongoing need to turn engineering milestones into productive assets and recurring revenue.
Automated analysis for informational purposes only — not investment advice.
Q2 FY2026
When: 2026-11-10
Revenue compared with the 1.2 million dollar benchmark for quarter 2 of fiscal year 2026 ended 2026-06-30
Net loss compared with the 48.5 million dollar benchmark for quarter 2 of fiscal year 2026 ended 2026-06-30
When: Fiscal year 2026
Operating cash use within guidance of 120 million dollars to 150 million dollars
The analyst consensus available through 2026-10-20 gives a Buy recommendation and an average price target of 77.88 dollars, within a range of 41 dollars to 130 dollars. The wide range reflects substantial differences in estimates of when Aurora, fuel and isotope projects will become commercial businesses. Citi lowered its target on 2026-08-10 to 57.5 dollars from 76 dollars, while UBS lowered its target on 2026-09-25 to 41 dollars, placing execution and growth assumptions under review. The valuation score, which measures relative valuation within the industry, was 17 out of 100 using data as of 2026-06-30, a weaker score than most companies in the industry.
Figures in the text are as of 2026-10-20; the live price is shown at the top of the page.
Oklo aims to develop, own and operate Aurora plants to sell electricity and heat under long-term commercial arrangements. In parallel, it is building capabilities for fuel fabrication and recycling and isotope production, with a planned 1.2 gigawatt energy complex in Ohio. Revenue for quarter 2 of fiscal year 2026, ended 2026-06-30, was approximately 1.2 million dollars, while net income remained negative at 48.5 million dollars. The model's success therefore remains tied to turning projects into operating assets that generate recurring revenue.
Groves achieved its first sustained nuclear chain reaction in early August 2026, after major construction was completed within 229 days. However, management said on the 2026-08-07 call that reaching production of research and development quantities could take approximately 12 months from the date of the call. It indicated that the isotope business's first revenue would likely come from the NRC-licensed Idaho laboratory, before Groves. Offtake discussions were ongoing with several companies, making the operating milestone distinct from demonstrating large-scale sales.
Cash and short-term investments in quarter 2 of fiscal year 2026, ended 2026-06-30, totaled approximately 1.6 billion dollars against total debt of 700000 dollars, according to EL7 data. However, on 2026-08-07, management raised fiscal year 2026 operating cash use guidance to 120 million dollars to 150 million dollars, and spending on property, plant and equipment to 400 million dollars to 500 million dollars. The diluted share count also rose in the same quarter to 176.2 million shares, compared with 140.1 million shares in quarter 2 of fiscal year 2025, an increase of 25.8% compared with the same quarter of the previous fiscal year. Liquidity supports execution, but it does not eliminate the dilution effect that has already emerged.
Oklo is working on construction, procurement and fuel fabrication to support Aurora INL's planned startup in 2028. Equipment for the A3F facility is targeted for installation and commissioning in 2027 to convert used EBR-II materials into fuel for the first reactor. The Centrus memorandum addresses supplies for up to 5 plants, with deliveries expected to begin in 2029, and still requires a definitive agreement. Management clarified on 2026-08-07 that it had not yet finalized total project cost guidance with Kiewit, leaving cost, fuel and execution as key areas to monitor.
Over the 90 days through 2026-10-20, 41 sales by 8 insiders were recorded, totaling 26.3 million dollars. These transactions included 17.6 million dollars under prearranged 10b5-1 trading plans and 8.7 million dollars outside those plans. No open-market purchases were recorded during the same period, and sales by the largest seller, an executive officer, totaled 13.9 million dollars.